Early Detection of Prostate Cancer, An Issue of Urologic Clinics, Volume 41-2 (Hardcover)

PSA screening remains highly controversial due to several important disadvantages. More PSA is produced with prostatic enlargement and in other benign conditions such as urinary tract infections. False positive tests can then lead to unnecessary diagnostic workup with invasive prostate biopsy. Another major problem with screening programs in general is overdiagnosis of cancers that would not have caused harm during the patient's lifetime. For example, many prostate cancers have a relatively indolent behavior so may not require diagnosis or treatment in a patient with limited life expectancy. All forms of prostate cancer treatment have potential urinary and sexual side effects, so reducing overdiagnosis and overtreatment are critical public health issues. Because screening has many proven benefits but also significant harms, there are widely disparate guidelines on prostate cancer screening from major organizations worldwide. This issue of the Urologic Clinics will provide insights into the many different prostate cancer guidelines and related policy issues.

General

Imprint:	Elsevier - Health Sciences Division
Country of origin:	United States
Series:	The Clinics: Internal Medicine
Release date:	April 2014
First published:	2014
Authors:	Stacy Loeb
Dimensions:	251 x 182 x 12mm (L x W x T)
Format:	Hardcover
ISBN-13:	978-0-323-29725-7
Categories:	Books > Medicine > Clinical & internal medicine > Urology & urogenital medicine Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General Promotions
LSN:	0-323-29725-0
Barcode:	9780323297257

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!